Happy to share this new paper that came out today: https://t.co/iAJbRq66po We present the General Change Mechanisms Questionnaire (GCMQ), a psychometric tool designed to assess 5 general change mechanisms of psychotherapy in the context of psychedelic experiences. 1/ 🧵↓

Full text (open access):

New theory paper in Psychological Review: Im short, we propose that effective psychedelic therapy employs the context-dependent effects of psychedelic drugs to engage & augment the same psychological change processes that underlie all effective psychotherapies. Full text ⬇️

Should we be viewing #Psychedelics as tools rather than treatments? Authors of a new DSPL publication suggest this reframing could help resolve current regulatory challenges. https://t.co/l9weS2J1qq

Neat new paper out in our journal Drug Science, Policy and Law: Reframing psychedelic regulation: Tools, not treatments - Max Wolff, Natalie Gukasyan, Leor Roseman, Paul Liknaitzky, 2025

* NEW PAPER just published * Well done @trpwolff for driving it! alongside co-authors @LeorRoseman and Natalie Gukasyan. I think this idea has potential for significant impact in psychedelic drug development. /1 🧵 👇 📄 https://t.co/RW9aniUD9y

We’re launching the Monash Psychedelic Education Program in 2025! Registrations are NOW OPEN for undergraduate and postgraduate education in psychedelic science and therapies! Options for EVERYONE, ANYWHERE. Clinical training coming in 2026! Visit: https://t.co/PplAf4iJl9

Today 6PM UTC+2: Psychologist and psychotherapist, leader of MIND Foundation’s Augmented Psychotherapy Training program Max Wolff @trpwolff will present a free webinar about the qualities and competencies that psychedelic therapists should have and develop. Links in comment!

Follow me on #bluesky: @robincarhartharris.bsky.social https://t.co/oFEJJ0Cc0J

"psychedelics, the lay term for substances classified as hallucinogens" Interesting paper, written from an 'outsider' perspective on psychedelics, with valid criticisms & some (forgivable) misunderstandings. Good to see critical people from other fields begin to engage!

I am slowly migrating to @bluesky it feels nice there :) 🦋

https://t.co/uixKGqKFrK

@trpwolff This is excellent, congratulations to all and thank you for the summary!

Yes. hope to see more appropriate psychometric tools enter the field 👍

https://t.co/SAd4djHZKx

Time to move!

Where the skies are blue…

Did you know that @mind_europe awards scholarships (up to 100% discount on course fees) to promote access to its APT psychedelic therapy training program? Apply now for upcoming courses in March (in German) or Nov 2025 (in English). https://t.co/vCvxRI5CPV

Wonderful to see this idea spreading! Treat psychedelics as what they are: Tools, not treatments. The role of anesthetics in surgery is a helpful analogy.

It’s here. Readers asked me to expand my last book that debunked Bessel van der Kolk’s book The Body Keep The Score. I tripled the size and number of claims debunked by covering his false claims about treatment and related issues. Available as paperback or eBook on Amazon.

Why do anesthetics drugs get approved easily, even though treatment outcomes are hopelessly 'confounded' by surgery & functional unblinding is inevitable when testing them against placebo? Because drug developers & regulators acknowledge that these are *tools*, not treatments.